Targeting the IDO1/TDO2–KYN–AhR Pathway for Cancer Immunotherapy – Challenges and Opportunities
Year: 2017
Type: review
Authors: Jae Eun Cheong, Lijun Sun
Institutions: Beth Israel Deaconess Medical Center, Harvard University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2775687989
